Surf Therapeutics
Agent48Agent Readiness: 48/100. Above median. Measured by StartupHub.ai. Median 41.Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.
About
Surf Therapeutics is developing a non-invasive ultrasound neuromodulation platform to treat chronic inflammatory disorders by stimulating the spleen-brain axis, known as the cholinergic anti-inflammatory pathway. Their patented BROAD-BEAM ULTRASOUND STIMULATION technology activates nerves to release neurotransmitters that signal the immune system to restore balance and calm inflammation. This platform aims to provide therapeutic benefits for conditions such as Rheumatoid Arthritis, Psoriasis/Psoriatic Arthritis, and Multiple Sclerosis.
Key facts
At-a-glance profile data
- Website
- surftherapeutics.com
- Headquarters
- Austin, United States
- Founded
- 2022
- Employees
- 10
- Total funding
- $6M (Seed)
- Business model
- B2B2C
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 17 Mar 2026 | Seed | $6M | - |
Tech stack
Detected on surftherapeutics.com, last scanned 22 Sept 2026. Run your own scan
- CMS / Builders
- Framer
- Email provider
- Microsoft 365
Frequently asked
How much funding has Surf Therapeutics raised?
Surf Therapeutics has raised a total of $6M in funding. The most recent round on record is Seed.
How many employees does Surf Therapeutics have?
Surf Therapeutics has approximately 10 people on record.